Clinical Trials Browser

Phase 3 × Prednisolone × Genitourinary × Clear all

Prostatic Neoplasms

NCT06764485 2026-01-28

rechARge

Phase 3 Recruiting

960 enrolled

Genitourinary

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT07365995 2026-01-26

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

Phase 3 Not yet recruiting

736 enrolled

Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT05288166 2025-06-27

CYCLONE 3

Phase 3 Active not recruiting

925 enrolled 12 charts

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms, Urogenital Neoplasms

NCT03072238 2025-06-06

IPATential150

Phase 3 Completed

1,101 enrolled 35 charts

Genitourinary

Prostatic Neoplasms

NCT03834519 2025-05-18

KEYLYNK-010

Phase 3 Completed

793 enrolled 23 charts

Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT02288247 2025-04-08

PRESIDE

Phase 3 Completed

688 enrolled 13 charts

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT02043678 2025-02-19

ERA 223

Phase 3 Completed

806 enrolled 32 charts

Genitourinary

Prostatic Neoplasms

NCT06768255 2025-01-10

mCRPC

Phase 3 Not yet recruiting

400 enrolled

Genitourinary

Abiraterone Acetate

NCT01308580 2017-04-17

PROSELICA

Phase 3 Completed

1,200 enrolled 25 charts

Genitourinary

Prostatic Neoplasms

NCT00519285 2016-07-22

VENICE

Phase 3 Completed

1,224 enrolled 21 charts

Genitourinary

Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

Clinical Trials

MK-2400-001

rechARge

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

CYCLONE 3

IPATential150

KEYLYNK-010

PRESIDE

ERA 223

mCRPC

PROSELICA

VENICE